BRPI0414027A - combinations of a pyrimidine containing nnrti with inhibitors of tr - Google Patents
combinations of a pyrimidine containing nnrti with inhibitors of trInfo
- Publication number
- BRPI0414027A BRPI0414027A BRPI0414027-3A BRPI0414027A BRPI0414027A BR PI0414027 A BRPI0414027 A BR PI0414027A BR PI0414027 A BRPI0414027 A BR PI0414027A BR PI0414027 A BRPI0414027 A BR PI0414027A
- Authority
- BR
- Brazil
- Prior art keywords
- combinations
- inhibitors
- nnrti
- pyrimidine
- pyrimidine containing
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMBINAçõES DE UMA PIRIMIDINA QUE CONTêM NNRTI COM INIBIDORES DE TR". A presente invenção refere-se a combinações de uma pirimidina que contém NNRTI denominada TMC278 com inibidores de nucleosídeo transcriptase reversa tais como entricitabina, lamivudina ou abacavir e/ou inibidores de nucleotídeo transcriptase reversa tal como tenofovir útil para o tratamento de pacientes infectados com HIV ou para a prevenção de transmissão ou infecção por HIV."COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH TR INHIBITORS". The present invention relates to combinations of an NNRTI-containing pyrimidine called TMC278 with nucleoside reverse transcriptase inhibitors such as entricitabine, lamivudine or abacavir and / or nucleotide reverse transcriptase inhibitors such as tenofovir useful for the treatment of HIV-infected patients. for the prevention of HIV transmission or infection.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49977103P | 2003-09-03 | 2003-09-03 | |
| EP03103275 | 2003-09-03 | ||
| EP03103319 | 2003-09-08 | ||
| US10333503A | 2003-09-10 | 2003-09-10 | |
| EP03103668 | 2003-10-02 | ||
| US50848603P | 2003-10-03 | 2003-10-03 | |
| PCT/EP2004/052028 WO2005021001A1 (en) | 2003-09-03 | 2004-09-03 | Combinations of a pyrimidine containing nnrti with rt inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0414027A true BRPI0414027A (en) | 2006-10-24 |
Family
ID=37137324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0414027-3A BRPI0414027A (en) | 2003-09-03 | 2004-09-03 | combinations of a pyrimidine containing nnrti with inhibitors of tr |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0414027A (en) |
-
2004
- 2004-09-03 BR BRPI0414027-3A patent/BRPI0414027A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20061374L (en) | Combinations of a pyrimidine containing NNRTI with RT inhibitors | |
| IL164491A0 (en) | Non nucleoside reverse transcriptase inhibitors | |
| WO2006114065A3 (en) | Use of compounds to inhibit neoplasia | |
| BR0310021A (en) | Compounds containing microbicidal pyrimidine or triazine | |
| BRPI0313664B8 (en) | nucleoside phosphorylase and nucleosidases inhibitor compounds, their compositions and their uses | |
| SI2057165T1 (en) | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases | |
| BRPI0513196A (en) | antiviral topical formulations | |
| UY26205A1 (en) | DERIVATIVES OF INDOLOXOACETIL PIPERAZINA ANTIVIRICOS | |
| BRPI0511078A (en) | cyclic pyrimidinone compounds, composition comprising them, method of inhibition and use | |
| BR0211750A (en) | Antiviral agent | |
| BR0004786A (en) | Pharmaceutically active compounds | |
| WO2007027248A3 (en) | 3', 5' - cyclic nucleoside analogues for treatment of hcv | |
| DE69911448D1 (en) | PYRAZOLOPYRIMIDINONE, CGMP PDE5 INHIBITORS, FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISORDERS | |
| ATE552259T1 (en) | INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND NUCLEOSIDASES | |
| WO2005023270A3 (en) | Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors | |
| BR9916849A (en) | Analogs of antiviral nucleosides | |
| EA200600522A1 (en) | COMBINATION OF PYRIMIDINS-CONTAINING NNRTI WITH REVERSE TRANSCRIPTASE INHIBITORS | |
| DE60111254D1 (en) | USE OF PDE5 INHIBITORS FOR THE TREATMENT OF PREVIOUS EJACULATION | |
| AR102104A2 (en) | COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS | |
| BR0309684A (en) | Treatment of pain with ifendropil | |
| AR046812A1 (en) | COMBINATIONS OF A NON-NUCLEOSIDE INVERSE TRANSCRIPT INHIBITOR (NNRTI) WITH PYRIMIDINE CONTENT WITH INVERSE TRANSCRIPT INHIBITORS | |
| CY1116565T1 (en) | Combinations of a pyrimidine containing NNRTI with RT inhibitors | |
| HN2006029085A (en) | PHARMACEUTICAL COMPOUNDS BASED ON A REVERSE AND MELDONIUM TRANSCRIPT INHIBITOR | |
| ECSP992988A (en) | HIV REVERSE TRANSCRIPTASE INHIBITORS | |
| DE60307616D1 (en) | FARNESYL TRANSFERASE INHIBITING TRICYCLIC QUINAZOLE DERIVATIVES SUBSTITUTES WITH CARBIDE-BONDED IMIDAZOLS OR TRIAZOLS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: TIBOTEC PHARMACEUTICALS (IE) |
|
| B25D | Requested change of name of applicant approved |
Owner name: JANSSEN R AND D IRELAND (IE) |
|
| B25A | Requested transfer of rights approved |
Owner name: JANSSEN SCIENCES IRELAND UC (IE) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |